D.Western Therapeutics Institute, Inc. Logo

D.Western Therapeutics Institute, Inc.

Biotechnology firm developing drugs from a proprietary protein kinase inhibitor library.

4576 | T

Overview

Corporate Details

ISIN(s):
JP3548740004
LEI:
Country:
Japan
Address:
名古屋市中区錦一丁目18番11号

Description

D.Western Therapeutics Institute, Inc. is a biotechnology company focused on the research, discovery, and development of innovative pharmaceutical drugs. The company's core technology is centered on a proprietary compound library with a primary focus on inhibitors, particularly protein kinase inhibitors. Its drug discovery and development business aims to provide patients with more effective and beneficial treatments than conventional drugs. A notable product developed from its research is the ophthalmic solution GLANATEC.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2020-08-13 08:33
四半期報告書-第23期第2四半期(令和2年4月1日-令和2年6月30日)
Japanese 160.9 KB
2020-05-14 08:37
四半期報告書-第23期第1四半期(令和2年1月1日-令和2年3月31日)
Japanese 122.9 KB
2020-03-26 07:00
有価証券報告書-第22期(平成31年1月1日-令和1年12月31日)
Japanese 903.5 KB
2019-11-14 07:37
四半期報告書-第22期第3四半期(2019/07/01-2019/09/30)
Japanese 117.3 KB
2019-08-09 02:47
四半期報告書-第22期第2四半期(2019/04/01-2019/06/30)
Japanese 141.0 KB
2019-05-15 08:33
四半期報告書-第22期第1四半期(2019/01/01-2019/03/31)
Japanese 116.3 KB
2019-03-28 07:00
有価証券報告書-第21期(平成30年1月1日-平成30年12月31日)
Japanese 885.9 KB
2018-11-09 01:20
四半期報告書-第21期第3四半期(2018/07/01-2018/09/30)
Japanese 127.4 KB
2018-08-10 02:12
四半期報告書-第21期第2四半期(2018/04/01-2018/06/30)
Japanese 153.8 KB
2018-05-11 03:10
四半期報告書-第21期第1四半期(2018/01/01-2018/03/31)
Japanese 128.1 KB
2018-03-29 08:01
有価証券報告書-第20期(平成29年1月1日-平成29年12月31日)
Japanese 925.2 KB
2017-11-10 01:06
四半期報告書-第20期第3四半期(2017/07/01-2017/09/30)
Japanese 118.5 KB
2017-08-10 08:32
四半期報告書-第20期第2四半期(2017/04/01-2017/06/30)
Japanese 161.2 KB
2017-05-15 08:37
四半期報告書-第20期第1四半期(2017/01/01-2017/03/31)
Japanese 134.7 KB
2017-03-23 06:32
有価証券報告書-第19期(2016/01/01-2016/12/31)
Japanese 841.3 KB

Automate Your Workflow. Get a real-time feed of all D.Western Therapeutics Institute, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for D.Western Therapeutics Institute, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for D.Western Therapeutics Institute, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

1NKEMIA Logo
Biotechnology company providing R&D and services for the life sciences sector.
Spain
IKM
2cureX AB Logo
Develops an IVD test using 3D tumoroids to predict patient response to cancer drugs.
Sweden
2CUREX
Abera Bioscience AB Logo
Develops mucosal vaccines using a proprietary Outer Membrane Vesicle (OMV) platform.
Sweden
ABERA
Clinical-stage biopharma developing therapeutics for oncology and viral diseases.
South Korea
203400
ABL Bio Inc. Logo
Develops bispecific antibody therapeutics for oncology and neurodegenerative diseases.
South Korea
298380
Abpro Holdings, Inc. Logo
Clinical-stage biotech developing antibody therapeutics for oncology and ophthalmology.
United States of America
ABP
Absci Corp Logo
A generative AI drug creation company developing biologic medicines.
United States of America
ABSI
Achiko AG Logo
A digital services platform for cross-border business compliance and engagement.
Switzerland
ACHI
Active Biotech Logo
Biotechnology company developing drugs for oncology and inflammatory eye disorders.
Sweden
ACTI
Adagene Inc. Logo
Clinical-stage biotech developing antibody-based immunotherapies for oncology.
United States of America
ADAG

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.